Search results
Showing 6796 to 6810 of 7691 results
Masitinib for treating relapsed or refractory peripheral T-cell non-Hodgkin lymphoma [ID1125]
Discontinued [GID-TA11173]
Atezolizumab with cobimetinib for untreated BRAF wild-type metastatic melanoma [ID1470]
Discontinued [GID-TA10354]
Lenalidomide with R-CHOP for untreated activated diffuse large B-cell lymphoma [ID1611]
Discontinued [GID-TA10480]
Discontinued [GID-TA10284]
Discontinued [GID-TA10166]
Nivolumab with ipilimumab for previously treated extensive stage small-cell lung cancer [ID1228]
Discontinued [GID-TA10203]
NGR-TNF for previously treated advanced malignant pleural mesothelioma [ID655]
Discontinued [GID-TA10183]
Discontinued [GID-TA10208]
Pembrolizumab with epacadostat for untreated malignant melanoma [ID1423]
Discontinued [GID-TA10330]
Discontinued [GID-TAG394]
Guadecitabine for untreated acute myeloid leukaemia [ID1411]
Discontinued [GID-TA10325]
Ibrutinib for treating relapsed or refractory follicular lymphoma and marginal zone lymphoma [ID977]
Discontinued [GID-TA11238]
Capecitabine for the treatment of advanced pancreatic cancer [ID127]
Discontinued [GID-TA11239]
Pazopanib for adjuvant treatment of locally advanced renal cell carcinoma [ID1091]
Discontinued [GID-TA11240]
Canakinumab and tocilizumab for treating systemic juvenile idiopathic arthritis [ID983]
Discontinued [GID-TA11241]